toxylact

The first professional lActological database in the word

Loperamide (ATC A07DA03) is a peripherally acting opioid antidiarrheal that reduces intestinal motility and stool frequency, and at standard doses is widely regarded as compatible with breastfeeding because it is minimally absorbed, reaches very low levels in breast milk, and has negligible oral bioavailability in the infant.atcddd.fhi+6

ATC A07DA03 overview

ATC code A07DA03 designates loperamide within the “Antipropulsives” subgroup of antidiarrheals, distinguishing it from other motility‑reducing opioids such as diphenoxylate and opium preparations. Loperamide oxide, a prodrug form, is classified separately at another 5th level, reflecting its distinct chemical entity despite similar antidiarrheal action.atcddd.fhi+2

Pharmacology and mechanism

Loperamide is a synthetic phenylpiperidine opioid that binds to μ‑opioid receptors in the gut wall, reducing propulsive peristalsis, increasing intestinal transit time, and enhancing fluid and electrolyte absorption. Due to extensive first‑pass metabolism and P‑glycoprotein‑mediated efflux at the blood–brain barrier, it has minimal central nervous system penetration at therapeutic doses, so its action is largely confined to the gastrointestinal tract.ncbi.nlm.nih+2

Therapeutic indications

Loperamide is indicated for short‑term control and relief of symptoms of acute diarrhea in adults and children above specified ages, and for chronic diarrhea associated with inflammatory bowel disease and for reducing ileostomy output. It is also used in travel‑related diarrhea and functional diarrhea when rapid symptomatic relief is needed, always in conjunction with oral rehydration and evaluation of underlying causes.clevelandclinic+2

Dosage and administration

For acute diarrhea in adults, the usual regimen is 4 mg (two capsules/tablets) initially after the first loose stool, followed by 2 mg after each subsequent loose stool, not exceeding 16 mg per day. Pediatric dosing is age‑ and weight‑adjusted, with lower maximum daily doses (for example 8 mg in older children), and many guidelines advise against its routine use in young children.clevelandclinic+2

Pharmacokinetics relevant to lactation

Loperamide acts mainly locally on the gut wall and is minimally absorbed into maternal blood, leading to very low systemic exposure. LactMed and other references state that only small amounts, if any, pass into breast milk, and given poor infant oral absorption and efflux transporters, clinically relevant exposure in the breastfed infant is unlikely.ncbi.nlm.nih+3

Maternal safety and adverse effects

When used short‑term and at recommended doses, loperamide is generally well tolerated; common adverse effects include constipation, abdominal cramps, and, occasionally, dizziness or mild drowsiness. Serious cardiac events (for example QT prolongation, arrhythmias) have been reported mainly with misuse or high off‑label doses, not with standard antidiarrheal use.ncbi.nlm.nih+2

Lactation safety assessment

LactMed explicitly states that use of loperamide during breastfeeding in standard doses is unlikely to affect the infant. Breastfeeding‑specific fact sheets and expert centers note that loperamide is poorly absorbed and that minimal blood levels mean minimal milk levels, making it a suitable antidiarrheal for breastfeeding mothers when an antipropulsive is needed. The NHS and other national guidance similarly consider it acceptable in breastfeeding, with no expected infant side effects at usual doses.ncbi.nlm.nih+5

Potential effects on the breastfed infant

Because only tiny amounts reach milk and infant absorption is low, direct opioid‑related effects such as sedation or respiratory depression are not expected in healthy, full‑term infants when mothers use loperamide appropriately. As a precaution, guidelines recommend observing the infant for changes in feeding, constipation, or unusual irritability and seeking medical advice if concerns arise.ncbi.nlm.nih+3

Practical recommendations in breastfeeding

For breastfeeding women with acute diarrhea, best practice is to continue breastfeeding, use oral rehydration salts to restore fluid and electrolyte balance, and consider loperamide as the preferred antipropulsive when symptom control is necessary. Use should be short‑term at labeled doses, avoiding prolonged or high‑dose courses, and clinicians should document the indication, dose, duration, and infant monitoring, especially in premature or medically fragile infants where any opioid exposure warrants extra caution.medicalguidelines.msf+5

Role among antipropulsives

Within the A07DA subgroup, loperamide offers effective symptomatic control with a substantially better lactation risk profile than centrally acting opioids such as diphenoxylate or opium tincture, which pose higher risks of infant sedation and respiratory depression. In a toxico‑lactological framework, its minimal systemic exposure, low milk transfer, and strong safety consensus make loperamide the antidiarrheal of choice for breastfeeding mothers when non‑pharmacologic measures alone are insufficient.atcddd.fhi+5

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.